Taro pharmaceutical inc, Company

The Manpasand scrips hit the lower circuit limit of 20 per cent on Monday. The trading stopped when it was priced at Rs 88 a stock, Rs 22 or 20 pet cent down from its previous close.The trading in a particular stock and even an index is halted by the exchanges when it hits a lower or upper circuit breaker.This is not the first such occasion, the stock had hit a lower 20 per cent circuit even in May 2018 after its auditor Deloitte Haskins and Sells India quit the audit process midway due to transparency issues.The company on Saturday informed that Vishal Sood, Non-Executive Director of the Company has tendered resignation from the post of Director of the Company with immediate effect May 24."This resignation is mainly due to Search from GST departmental," the company said in a regulatory filing.According to a BSE filing by the company, the Commissioner of Central GST and Customs carried out search and seizure proceedings at various premises of the company on May 23 and further inquiry was conducted on May 24 at the GST Bhavan office here."Abhishek Singh, Whole Time Director, Paresh Thakkar, Chief Financial Officer of the company and (Singh's brother) Harshvardhan Singh, are under judicial custody of authority from yesterday, i.e., May 24, 2019. The company is contesting these allegations in accordance with the due process of law," the company said in the filing."Considering the present status of the case, estimated impact on the company and amount involved is not identifiable till the outcome in the matter."A CGST statement, released on Friday, stated that searches were conducted on various premises of the company on May 23, following which a racket of creating fake/dummy units for availing fraudulent credit and committing tax evasion of Rs 40 crore involving turnover of approximate Rs 300 crore had surfaced.The investigations revealed a nationwide network of 30 dummy companies that were used by Manpasand Beverages for claiming illegal credit. The agencies were still ascertaining the exact beneficiaries of such dubious deals.( With inputs from IANS )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Taro Pharmaceutical IncFOLLOW

Taro pharmaceutical inc, Latest News

Business :Saudi Aramco lists RIL investment, expansion in India in monster IPO prospectus

Saudi Aramco launched has its prospectus for the worlds biggest IPO with a potential largest ever company valuation of estimates ranging wildly from $1.2-2.3 trillion, with an India angle-acquiring 20 per cent in Reliance Industries Limited (RIL) oil ...

Business :Infosys must act with urgency, calm investors, workers first: Experts as stock tumbles

As Infosys (NYSE: INFY) reels from the onslaught of a whistleblower complaint alleging "unethical practices" by the companys Chief Executive Officer (CEO) Salil Parekh and Chief Financial Officer (CFO) Nilanjan Roy, crisis communications experts are ...

National :Singh brothers ran 7 shady firms as one entity to defraud RFL ( Exclusive-3)

The Economic Offences Wing FIR against the Singh Brothers in the Religare Group fraud case shows their chicanery and duplicity. It points out to how Modland, Platinum, Prius and ANR entities controlled by Shivinder Mohan Singh (SMS) and Malvinder Mo ...

National :IndiGo's Bhatia unlikely to relent on change in control structure

Even as a dispute rages by the day with letter-bombs being dropped by the warring promoters, IndiGo co-promoter Rahul Bhatia is unlikely to budge from his position and agree to dilute airline's control structure that gives him right to nominate Chair ...

National :Manpasand scrips tumble on MD, CFO's arrest, 2nd time in 2 years

Manpasand Beverages scrips hit lower circuit on the Bombay stock exchange over MD and CFO's arrest facing allegations of Goods and Services Tax (GST) fraud. ...